Cymabay Therapeutics Inc (NASDAQ:CBAY)

2.95
Delayed Data
As of 4:00pm ET
 -0.04 / -1.34%
Today’s Change
2.76
Today|||52-Week Range
6.56
-12.72%
Year-to-Date
No recent news for Cymabay Therapeutics Inc.

Today’s Trading

Previous close2.99
Today’s open2.95
Day’s range2.88 - 2.98
Volume22,937
Average volume (3 months)503,284
Market cap$245.5M
Data as of 4:00pm ET, 01/25/2022

Growth & Valuation

Earnings growth (last year)+51.74%
Earnings growth (this year)-53.21%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...+3.16+1.87%
--FV Pharma Internatio...0.000.00%
----
NEUNNeuroGenesis Inc0.000.00%
Data as of 4:00pm ET, 01/25/2022

Financials

Next reporting dateMarch 24, 2022
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$51.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Newark, California

Forecasts